By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Novozymes A/S

Novozymes A/S (NVZMY)

OTC Market Data in USD, Fundamentals in DKK
$63.22
-$0.16
-0.25%
Last Update: 11 Sept 2025, 19:05
$29.58B
Market Cap
134.59
P/E Ratio (TTM)
1.11%
Forward Dividend Yield
$53.95 - $75.99
52 Week Range

NVZMY Stock Price Chart

Explore Novozymes A/S interactive price chart. Choose custom timeframes to analyze NVZMY price movements and trends.

NVZMY Company Profile

Discover essential business fundamentals and corporate details for Novozymes A/S (NVZMY) to support your stock research and investment decisions.

Sector

Basic Materials

Industry

Chemicals - Specialty

IPO Date

20 Jan 2010

Employees

10.58K

CEO

Ester Baiget

Description

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

NVZMY Financial Timeline

Browse a chronological timeline of Novozymes A/S corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 Feb 2026

Earnings released on 21 Aug 2025

EPS came in at $0.05 falling short of the estimated $0.67 by -93.17%, while revenue for the quarter reached $160.69M , missing expectations by -97.99%.

Dividend declared on 21 Aug 2025

A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 11 Sept 2025.

Earnings released on 8 May 2025

EPS came in at $0.06 falling short of the estimated $0.44 by -86.53%, while revenue for the quarter reached $158.60M , missing expectations by -98.05%.

Dividend declared on 10 Mar 2025

A dividend of $0.61 per share was announced, adjusted to $0.61. The dividend was paid on 23 Apr 2025.

Earnings released on 27 Feb 2025

EPS came in at $0.07 falling short of the estimated $1.10 by -93.33%, while revenue for the quarter reached $277.05M , missing expectations by -96.59%.

Earnings released on 26 Dec 2024

EPS came in at $0.38 falling short of the estimated $0.57 by -34.26%, while revenue for the quarter reached $1.10B , missing expectations by -85.63%.

Earnings released on 28 Aug 2024

EPS came in at $0.12 falling short of the estimated $0.71 by -82.68%, while revenue for the quarter reached $983.65M , missing expectations by -53.21%.

Dividend declared on 28 Aug 2024

A dividend of $0.29 per share was announced, adjusted to $0.30. The dividend was paid on 18 Sept 2024.

Earnings released on 26 Jun 2024

EPS came in at $0.12 falling short of the estimated $0.56 by -78.00%, while revenue for the quarter reached $981.04M , missing expectations by -7.27%.

Dividend declared on 10 Apr 2024

A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 20 May 2024.

Earnings released on 1 Feb 2024

EPS came in at $0.36 falling short of the estimated $0.47 by -23.40%, while revenue for the quarter reached $679.26M , beating expectations by +0.88%.

Earnings released on 26 Oct 2023

EPS came in at $0.49 surpassing the estimated $0.42 by +16.67%, while revenue for the quarter reached $628.74M , missing expectations by -0.14%.

Dividend declared on 12 Oct 2023

A dividend of $0.59 per share was announced, adjusted to $0.60. The dividend was paid on 1 Nov 2023.

Earnings released on 9 Aug 2023

EPS came in at $0.32 falling short of the estimated $0.42 by -23.81%, while revenue for the quarter reached $616.07M , missing expectations by -4.41%.

Earnings released on 26 Apr 2023

EPS came in at $2.82 falling short of the estimated $2.99 by -5.69%, while revenue for the quarter reached $673.98M , beating expectations by +2.00%.

Dividend declared on 30 Jan 2023

A dividend of $0.85 per share was announced, adjusted to $0.88. The dividend was paid on 22 Mar 2023.

Earnings released on 26 Jan 2023

EPS came in at $0.44 surpassing the estimated $0.41 by +7.82%, while revenue for the quarter reached $654.16M , beating expectations by +2.05%.

Earnings released on 3 Nov 2022

EPS came in at $0.56 surpassing the estimated $0.54 by +3.70%, while revenue for the quarter reached $572.34M , missing expectations by -1.90%.

Earnings released on 11 Aug 2022

EPS came in at $0.41 surpassing the estimated $0.39 by +5.13%, while revenue for the quarter reached $601.80M , beating expectations by +6.45%.

Earnings released on 26 Apr 2022

EPS came in at $0.45 surpassing the estimated $0.43 by +4.05%, while revenue for the quarter reached $650.07M , beating expectations by +5.42%.

Dividend declared on 4 Feb 2022

A dividend of $0.85 per share was announced, adjusted to $0.85. The dividend was paid on 5 Apr 2022.

Earnings released on 1 Feb 2022

EPS came in at $0.36 falling short of the estimated $2.38 by -84.87%, while revenue for the quarter reached $584.34M , beating expectations by +2.16%.

Earnings released on 26 Oct 2021

EPS came in at $0.48 falling short of the estimated $2.56 by -81.25%, while revenue for the quarter reached $586.79M , missing expectations by -0.80%.

Earnings released on 12 Aug 2021

EPS came in at $0.46 surpassing the estimated $0.41 by +12.20%, while revenue for the quarter reached $570.69M .

Earnings released on 27 Apr 2021

EPS came in at $0.51 surpassing the estimated $0.45 by +13.33%, while revenue for the quarter reached $596.56M .

Dividend declared on 1 Mar 2021

A dividend of $0.84 per share was announced, adjusted to $0.85. The dividend was paid on 31 Mar 2021.

Earnings released on 2 Feb 2021

EPS came in at $0.37 falling short of the estimated $0.42 by -11.90%, while revenue for the quarter reached $565.83M .

Earnings released on 21 Oct 2020

EPS came in at $0.40 , while revenue for the quarter reached $540.71M .

NVZMY Stock Performance

Access detailed NVZMY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run